Skip to main content
. 2017;18(3):593–597. doi: 10.22034/APJCP.2017.18.3.593

Table 2.

Profile of Patients with Hodgkin and Non-Hodgkin

Category Male Female Total
Hodgkin Lymphoma n = 25
Mixed Cellularity (MC) 4 (16%) 8 (32%) 12 (48%)
Lymphocyte Predominant (LP) 3 (12%) 2 (8%) 5 (20%)
Nodular Sclerosis (NS) 4 (16%) 4 (16%) 8 (32%)
Non-Hodgkin Lymphoma n= 25
Diffuse Large Cell Type 4 (16%) 10 (40%) 14 (56%)
Small Lymphocytic Lymphoma 1 (4%) 1 (4%)
High Grade Immunoblastic Lymphoma 1 (4%) 1 (4%)
Mixed Small and Large 2 (8%) 2 (8%)
Malignant T Cell 2 (8%) 2 (8%) 4 (16%)
Malignant B Cell 1 (4%) 1 (4%) 2 (8%)
Diffuse Mixed Large Cell 1 (4%) 1 (4%)